MRI lesion size is more important than the number of positive biopsy cores in predicting adverse features and recurrence after radical prostatectomy: implications for active surveillance criteria in intermediate-risk patients-Reference-Cited by-同舟云学术

MRI lesion size is more important than the number of positive biopsy cores in predicting adverse features and recurrence after radical prostatectomy: implications for active surveillance criteria in intermediate-risk patients

Published:2023-07-14 Issue: Volume: Page:
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Baboudjian Michael^ORCID,Uleri Alessandro,Beauval Jean-Baptiste,Touzani Alae,Diamand Romain^ORCID,Roche Jean-Baptiste,Lacetera Vito,Lechevallier Eric,Roumeguère Thierry,Simone Giuseppe^ORCID,Benamran Daniel^ORCID,Fourcade Alexandre,Fiard Gaelle,Peltier Alexandre,Ploussard Guillaume

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

https://www.nature.com/articles/s41391-023-00693-z.pdf

Reference29 articles.

1. Tosoian JJ, Mamawala M, Epstein JI, Landis P, Wolf S, Trock BJ, et al. Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer. J Clin Oncol. 2015;33:3379–85.

2. Tzeng M, Basourakos SP, Davuluri M, Nagar H, Ramaswamy A, Cheng E, et al. Evolving trends in the management of low-risk prostate cancer. Clin Genitourin Cancer. 2022;20:423–30.

3. Baboudjian M, Breda A, Rajwa P, Gallioli A, Gondran-Tellier B, Sanguedolce F, et al. Active surveillance for intermediate-risk prostate cancer: a systematic review, meta-analysis, and metaregression. Eur Urol Oncol. 2022;5:617–27.

4. Eastham JA, Auffenberg GB, Barocas DA, Chou R, Crispino T, Davis JW, et al. Clinically localized prostate cancer: AUA/ASTRO guideline, Part II: Principles of active surveillance, principles of surgery, and follow-up. J Urol. 2022;208:19–25.

5. Willemse PM, Davis NF, Grivas N, Zattoni F, Lardas M, Briers E, et al. Systematic review of active surveillance for clinically localised prostate cancer to develop recommendations regarding inclusion of intermediate-risk disease, biopsy characteristics at inclusion and monitoring, and surveillance repeat biopsy strategy. Eur Urol. 2022;81:337–46.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Active surveillance for low-risk prostate cancer with high tumor burden at biopsy: lessons learned from a contemporary radical prostatectomy cohort;World Journal of Urology;2024-09-09

2. Quantified treatment effect at the individual level is more indicative for personalized radical prostatectomy recommendation: implications for prostate cancer treatment using deep learning;Journal of Cancer Research and Clinical Oncology;2024-02-01

3. Likelihood of sampling prostate cancer at systematic biopsy as a function of gland volume and number of cores;Prostate Cancer and Prostatic Diseases;2024-01-06

4. Active surveillance in favorable intermediate-risk prostate cancer: A single-center experience;Progrès en Urologie;2023-09